Stock-Based Compensation

Our shareholders approved the adoption of and subsequent amendments to the Lancaster Colony Corporation 2005 Stock Plan (the “2005 Plan”). The 2005 Plan reserved 2,000,000 common shares for issuance to our employees and directors, and all awards granted under the 2005 Plan will be exercisable at prices not less than fair market value as of the date of the grant. The vesting period for awards granted under the 2005 Plan varies as to the type of award granted, but generally these awards have a maximum term of five years.

Stock-Settled Stock Appreciation Rights

We use periodic grants of stock-settled stock appreciation rights (“SSSARs”) as a vehicle for rewarding certain employees with long-term incentives for their efforts in helping to create long-term shareholder value. We calculate the fair value of SSSARs grants using the Black-Scholes option-pricing model. Our policy is to issue shares upon SSSARs exercise from new shares that had been previously authorized.

There were no SSSARs grants in the three months ended September 30, 2014. In August 2013, we granted SSSARs under the terms of the 2005 Plan. The following table summarizes information relating to this grant:



	Three Months Ended September 30, 2013
SSSARs granted	2
Weighted average grant date fair value per right	$	10.14
Weighted average assumptions used in fair value calculations:
Risk-free interest rate	0.61		%
Dividend yield	2.01		%
Volatility factor of the expected market price of our common stock	23.00		%
Weighted average expected life in years	2.68

For this grant, the volatility factor was estimated based on actual historical volatility of our stock for a time period equal to the term of the SSSARs. The expected average life was determined based on historical exercise experience for this type of grant. The SSSARs we grant vest one-third on the first anniversary of the grant date, one-third on the second anniversary of the grant date and one-third on the third anniversary of the grant date. As needed, we estimate a forfeiture rate for our SSSARs grants based on historical experience.

We recognize compensation expense over the requisite service period. Compensation expense was reflected in Cost of Sales or Selling, General and Administrative Expenses based on the grantees’ salaries expense classification. We recorded tax benefits and excess tax benefits related to SSSARs. These excess tax benefits were included in the financing section of the Condensed Consolidated Statements of Cash Flows. The following table summarizes our continuing operations SSSARs compensation expense and tax benefits recorded:



	Three Months Ended September 30,
	2014		2013
Compensation expense	$	354	$	297
Tax benefits	$	124	$	104
Intrinsic value of exercises	$	478	$	18
Excess tax benefits	$	167	$	6

The total fair values of SSSARs vested were as follows:



	Three Months Ended September 30,
	2014		2013
Fair value of vested rights	$	7	$	—

The following table summarizes the activity relating to SSSARs granted under the 2005 Plan for the three months ended September 30, 2014:



	Number of Rights		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value
Outstanding at beginning of year	358		$	76.75
Exercised	(33	)	$	64.00
Granted	—		$	—
Forfeited	(31	)	$	79.57
Outstanding at end of period	294		$	77.89	3.42	$	2,691
Exercisable and vested at end of period	52		$	65.23	1.95	$	1,040
Vested and expected to vest at end of period	288		$	77.86	3.42	$	2,637

At September 30, 2014, there was approximately $1.3 million of unrecognized compensation expense related to SSSARs that we will recognize over a weighted-average period of approximately 2 years.

Restricted Stock

We use periodic grants of restricted stock as a vehicle for rewarding our nonemployee directors and certain employees with long-term incentives for their efforts in helping to create long-term shareholder value.

There were no grants of restricted stock during the three months ended September 30, 2014. In August 2013, we granted 200 shares of restricted stock under the terms of the 2005 Plan. The grant date fair value was approximately $16,000 and the grant date fair value per award was $79.78. The restricted stock under this employee grant vests on the third anniversary of the grant date. As needed, we estimate a forfeiture rate for our restricted stock grants based on historical experience. Under the terms of our grants, employees receive dividends on unforfeited restricted stock regardless of their vesting status. No restricted stock vested during the three months ended September 30, 2014 and 2013.

We recognize compensation expense over the requisite service period. Compensation expense was reflected in Cost of Sales or Selling, General and Administrative Expenses based on the grantees’ salaries expense classification. We recorded tax benefits and excess tax benefits related to restricted stock. These excess tax benefits were included in the financing section of the Condensed Consolidated Statements of Cash Flows. The following table summarizes our continuing operations restricted stock compensation expense and tax benefits recorded:



	Three Months Ended September 30,
	2014		2013
Compensation expense	$	457	$	330
Tax benefits	$	160	$	115
Excess tax benefits	$	—	$	2

The following table summarizes the activity relating to restricted stock granted under the 2005 Plan for the three months ended September 30, 2014:



	Number of Shares		Weighted Average Grant Date Fair Value
Unvested restricted stock at beginning of year	58		$	79.09
Granted	—		$	—
Vested	—		$	—
Forfeited	(3	)	$	79.32
Unvested restricted stock at end of period	55		$	79.07

At September 30, 2014, there was approximately $2.1 million of unrecognized compensation expense related to restricted stock that we will recognize over a weighted-average period of approximately 2 years.